Benjamin Paluch

Stock Analyst at Roth MKM

(1.28)

# 3,680

Out of 5,141 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$57.63	+12.79%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$8.64	+96.76%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.64	+278.79%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $57.63

Upside: +12.79%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $8.64

Upside: +96.76%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.64

Upside: +278.79%